ロード中...
The Evolving Landscape of PD-1/PD-L1 Pathway in Head and Neck Cancer
Over the past 10 years, cancer immunotherapy has made significant progress in multiple cancer types and has been gradually been applied to clinical cancer care, in which the programmed cell death protein-1 (PD-1)/programmed cell death ligand 1 (PD-L1) pathway is one of the most attractive targets. C...
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7531035/ https://ncbi.nlm.nih.gov/pubmed/33072064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01721 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|